Cite
HARVARD Citation
Nath, K. et al. (2022). A short course of daratumumab in patients with multiple myeloma and minimal residual disease after induction therapy. Leukemia & lymphoma. 63 (14), pp. 3488-3492. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Nath, K. et al. (2022). A short course of daratumumab in patients with multiple myeloma and minimal residual disease after induction therapy. Leukemia & lymphoma. 63 (14), pp. 3488-3492. [Online].